POSTER 71

Inhibition of Structural Damage Progression with Guselkumab, a Selective IL-23i, in Participants with Active PsA: Results through Week 24 of the Phase 3b, Randomized, Double-Blind, Placebo-Controlled APEX Study

Philip J Mease, Christopher T Ritchlin, Laura C Coates, Alexa P Kollmeier, Bei Zhou, Yusang Jiang, Karen Bensley, Koeun Im, Rattandeep Batra, Soumya D. Chakravarty, Proton Rahman, Désirée van der Heijde

< Previous Poster | Next Poster >

Poster 71